Human Papillomavirus (HPV)-negative HNSCC organoids further confirmed that high p-mTOR/p-ERK expression correlates with worse survival and predicts therapeutic resistance to mTOR inhibitor everolimus [69]. This evidence concerns the gene MTOR and head and neck squamous cell carcinoma.